chrX-153935307-G-A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2

The NM_002910.6(RENBP):​c.1263C>T​(p.Pro421Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00058 in 914,749 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 130 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., 10 hem., cov: 23)
Exomes 𝑓: 0.00060 ( 0 hom. 120 hem. )

Consequence

RENBP
NM_002910.6 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0600

Publications

0 publications found
Variant links:
Genes affected
RENBP (HGNC:9959): (renin binding protein) The gene product inhibits renin activity by forming a dimer with renin, a complex known as high molecular weight renin. The encoded protein contains a leucine zipper domain, which is essential for its dimerization with renin. The gene product can catalyze the interconversion of N-acetylglucosamine to N-acetylmannosamine, indicating that it is a GlcNAc 2-epimerase. Transcript variants utilizing alternative promoters have been described in the literature. [provided by RefSeq, Jul 2008]
NAA10 (HGNC:18704): (N-alpha-acetyltransferase 10, NatA catalytic subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
NAA10 Gene-Disease associations (from GenCC):
  • microphthalmia, syndromic 1
    Inheritance: XL, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • NAA10-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: Broad Center for Mendelian Genomics, ClinGen, G2P
  • Ogden syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • microphthalmia, Lenz type
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant X-153935307-G-A is Benign according to our data. Variant chrX-153935307-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 2661762.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.06 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 10 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002910.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RENBP
NM_002910.6
MANE Select
c.1263C>Tp.Pro421Pro
synonymous
Exon 11 of 11NP_002901.2P51606-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RENBP
ENST00000393700.8
TSL:1 MANE Select
c.1263C>Tp.Pro421Pro
synonymous
Exon 11 of 11ENSP00000377303.3P51606-1
RENBP
ENST00000875215.1
c.1389C>Tp.Pro463Pro
synonymous
Exon 12 of 12ENSP00000545274.1
RENBP
ENST00000369997.7
TSL:5
c.1221C>Tp.Pro407Pro
synonymous
Exon 11 of 11ENSP00000359014.3A6NKZ2

Frequencies

GnomAD3 genomes
AF:
0.000435
AC:
48
AN:
110391
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000983
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000943
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000824
Gnomad OTH
AF:
0.000669
GnomAD2 exomes
AF:
0.000485
AC:
9
AN:
18543
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00125
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000600
AC:
483
AN:
804358
Hom.:
0
Cov.:
12
AF XY:
0.000585
AC XY:
120
AN XY:
205198
show subpopulations
African (AFR)
AF:
0.000118
AC:
2
AN:
16902
American (AMR)
AF:
0.000185
AC:
2
AN:
10798
Ashkenazi Jewish (ASJ)
AF:
0.0000843
AC:
1
AN:
11863
East Asian (EAS)
AF:
0.00
AC:
0
AN:
22402
South Asian (SAS)
AF:
0.00
AC:
0
AN:
30721
European-Finnish (FIN)
AF:
0.0000369
AC:
1
AN:
27087
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2071
European-Non Finnish (NFE)
AF:
0.000722
AC:
468
AN:
647812
Other (OTH)
AF:
0.000259
AC:
9
AN:
34702
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000435
AC:
48
AN:
110391
Hom.:
0
Cov.:
23
AF XY:
0.000305
AC XY:
10
AN XY:
32801
show subpopulations
African (AFR)
AF:
0.0000983
AC:
3
AN:
30527
American (AMR)
AF:
0.0000943
AC:
1
AN:
10603
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2623
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3480
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2709
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5864
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
234
European-Non Finnish (NFE)
AF:
0.000824
AC:
43
AN:
52186
Other (OTH)
AF:
0.000669
AC:
1
AN:
1494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000674
Hom.:
2

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
4.9
DANN
Benign
0.82
PhyloP100
0.060
PromoterAI
0.025
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781854646; hg19: chrX-153200760; API